
1. zh mikrobiol epidemiol immunobiol. 1999 jan-feb;(1):84-6.

[new approaches chemotherapy hiv infection].

[article russian]

karamova ev(1), sakhuriia ib, shelkanov miu, burunova vv, iaroslavtseva ng,
pavlova tv, kornilaeva gv.

author information: 
(1)ivanovsky research institute virology, moscow, russia.

the preclinical analysis effectiveness azt new compounds
(sulphatized derivate chitosan (sch) adamantileted sch, contents 10 and
18% adamantine) prepared basis chitosan (ch), carried the
use experimental clinical test system (the vitro model peripheral
blood mononuclears concrete patient) developed laboratory, presented. 
both combinations concentration 0.01 mkg/ml decreased hiv antigens till
6.4 8.6% accordingly, whilst initial sch hare caused less effect 4-5
fold.


pmid: 10096218  [indexed medline]

